Issue 35, 2023

A reliable QSPR model for predicting drug release rate from metal–organic frameworks: a simple and robust drug delivery approach

Abstract

During the drug release process, the drug is transferred from the starting point in the drug delivery system to the surface, and then to the release medium. Metal–organic frameworks (MOFs) potentially have unique features to be utilized as promising carriers for drug delivery, due to their suitable pore size, high surface area, and structural flexibility. The loading and release of various therapeutic drugs through the MOFs are effectively accomplished due to their tunable inorganic clusters and organic ligands. Since the drug release rate percentage (RES%) is a significant concern, a quantitative structure–property relationship (QSPR) method was applied to achieve an accurate model predicting the drug release rate from MOFs. Structure-based descriptors, including the number of nitrogen and oxygen atoms, along with two other adjusted descriptors, were applied for obtaining the best multilinear regression (BMLR) model. Drug release rates from 67 MOFs were applied to provide a precise model. The coefficients of determination (R2) for the training and test sets obtained were both 0.9999. The root mean square error for prediction (RMSEP) of the RES% values for the training and test sets were 0.006 and 0.005, respectively. To examine the precision of the model, external validation was performed through a set of new observations, which demonstrated that the model works to a satisfactory degree.

Graphical abstract: A reliable QSPR model for predicting drug release rate from metal–organic frameworks: a simple and robust drug delivery approach

Supplementary files

Article information

Article type
Paper
Submitted
04 Jan 2023
Accepted
05 Jun 2023
First published
17 Aug 2023
This article is Open Access
Creative Commons BY-NC license

RSC Adv., 2023,13, 24617-24627

A reliable QSPR model for predicting drug release rate from metal–organic frameworks: a simple and robust drug delivery approach

L. Tayebi, R. Rahimi, A. R. Akbarzadeh and A. Maleki, RSC Adv., 2023, 13, 24617 DOI: 10.1039/D3RA00070B

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. You can use material from this article in other publications, without requesting further permission from the RSC, provided that the correct acknowledgement is given and it is not used for commercial purposes.

To request permission to reproduce material from this article in a commercial publication, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party commercial publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements